White Guide and Orange Guide Formatting Project - Pfizer

Use of Pfizer Approved Speaker Slide Kits
Orange Guide – Chapter 9: Speaker Programs for HCPs
Q. Is a speaker required to use all slides contained in a Pfizer approved slide kit?
A. It depends. A speaker must appropriately emphasize all slides that relate to
safety, risks, and contraindications to ensure fair balance (these slides are
typically designated in EZSpeak as “mandatory” slides). Speakers are not
required to use slides addressing other issues as long as the information
presented is accurate and truthful, consistent with approved product labeling,
supported by substantial evidence, and includes a balanced discussion of
benefits and risks. (Note that for speaker slide decks intended for use with
consumers, all slides must be used.)
Review Policies with Speakers
Before the program, you are responsible for downloading a copy of the speaker’s slides from EZSpeak
and must hold a discussion with the speaker to review Pfizer’s promotional speaker policies and to
ensure that he or she understands Pfizer’s requirements for the presentation. A copy of Pfizer’s
Promotional Speaker Policy is provided to all speakers as part of their contract. Your pre-program
discussion with the speaker must include the items outlined in the Speaker Program Checklist located
at the beginning of this Chapter, including:
A reminder that the speaker is speaking on Pfizer’s behalf and that discussions must be on-
label;
A reminder that the speaker must present the current RC-approved slide deck, without any
unapproved materials or modifications, and that you will be prepared to project the slides
from your Pfizer laptop (except at roundtable programs where handouts may be used);
A reminder of the appropriate duration of the program (minimum of 45 minutes for venue
programs, or minimum of 30 minutes for programs with attendees in an in-office setting);
A reminder that the speaker must start the program by clearly stating that Pfizer is
sponsoring the presentation and that he/she is presenting on Pfizer’s behalf; and
A reminder that if an attendee asks the speaker a specific unsolicited off-label question, the
speaker may answer briefly, and limited to the specific question asked, after stating that the
information to be discussed is off-label and is based on the speaker’s personal experience or
opinion.
159
Rev. 09/12
Page 8 of 25